18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.

Gempt, Jens; Bette, Stefanie; Ryang, Yu-Mi; Buchmann, Niels; Peschke, Patrick; Pyka, Thomas; Wester, Hans-Jürgen; Forster, Stefan; Meyer, Bernhard; Ringel, Florian

doi:10.1016/j.ejrad.2015.01.022

Titel:: 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Dokumenttyp:: Journal Article; Research Support, Non-U.S. Gov't
Autor(en):: Gempt, Jens; Bette, Stefanie; Ryang, Yu-Mi; Buchmann, Niels; Peschke, Patrick; Pyka, Thomas; Wester, Hans-Jürgen; Forster, Stefan; Meyer, Bernhard; Ringel, Florian
Abstract:: Histopathological examination is the standard for grading and determination of diagnosis in intrinsic brain tumors though the possibility of malignization and tumor heterogeneity always bears the possibility of tumor under-grading or misjudgement regarding the estimation of prognosis. The aim of the present study was to evaluate the use of (18)F-FET-PET (FET-PET) for the grading and estimation of prognosis in newly diagnosed patients with intracranial gliomas in a clinical setting.Patients who were treated for a newly diagnosed intracranial glioma between January 2007 and May 2012, and had a preoperative FET-PET and MRI scan between were included. The ratio of counts in a tumor VOI (volume of interest) with maximum uptake to the respective counts in a background VOI was calculated to provide the tumor-to-normal (T/N) ratio. The clinical and histopathological data (tumor grading, pre- and postoperative neurological status, Karnofsky Performance Status Scale scores, and overall survival rates) were recorded.One hundred fifty-two patients (39 WHO II, 26 WHO III, 87 WHO IV) were included. The median T/N ratio was 2.81 (1.1-8.1). The median T/N ratio of low-grade glioma patients was 1.65 (1.1-3.7), and 3.14 (1.61-8.1, p<0.001) in high-grade glioma patients. The median survival for patients with WHO III tumors was 22.8 months (95% CI: 15.87%-NA) and 13.23 months (95% CI: 10.83-15.6.%) for patients with WHO IV tumors (p=0.0001). For T/N<=1.6, no deaths were recorded; for 1.63, median survival was 14.0 months (95% CI: 11.7-16.2%, p<0.001). The test of the maximally selected log-rank statistic resulted in a T/N ratio of 1.88 as the cut-off value, with the greatest difference in overall survival between patients with longer and shorter survival. The ROC curve for differentiation of low- vs. high-grade tumors with regard to the T/N ratio showed an area under the curve (AUC) of 0.903. Regarding the prognostic validity for overall survival ROC-curves for 12-month, 24-month and 48-month survival display a higher validity for the WHO-classification than for the imaging modalities though with an AUC of 0.847 for the 48-month survival T/N ratio and MRI contrast-enhancement have a high prognostic value as well.Our study suggests that FET-PET can predict prognosis and survival in patients harboring intracranial gliomas and serves as a valuable tool to supplement the established clinical and histopathological parameters.
Zeitschriftentitel:: Eur J Radiol
Jahr:: 2015
Band / Volume:: 84
Heft / Issue:: 5
Seitenangaben Beitrag:: 955-62
Sprache:: eng
Volltext / DOI:: doi:10.1016/j.ejrad.2015.01.022
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/25748815
Print-ISSN:: 0720-048X
TUM Einrichtung:: Fachgebiet Neuroradiologie (Prof. Zimmer); Klinik und Poliklinik für Nuklearmedizin; Neurochirurgische Klinik und Poliklinik
BibTeX